A tech-only 25-marker screening profile for peripheral blood specimens. An evaluation of specimen adequacy and cellular integrity will also be performed. Markers include CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11b, CD13, CD14, CD16, CD19, CD20, CD23, CD34, CD38, CD45, CD56, CD57, CD103, CD117, FMC 7, HLADR, Kappa, and Lambda.

A tech-only 20-marker screening profile for fresh tissue specimens. An evaluation of specimen adequacy and cellular integrity will also be performed. Markers include CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD14, CD19, CD20, CD23, CD34, CD38, CD45, CD56, CD57, CD200, FMC 7, Kappa and Lambda.

A tech-only 24-marker screening profile for bone marrow specimens. An evaluation of specimen adequacy and cellular integrity will also be performed. Markers include CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11b, CD13, CD14, CD16, CD19, CD20, CD33, CD34, CD38, CD45, CD56, CD57, CD64, CD117, HLADR, Kappa and Lambda.

A flow cytometry profile, with additional rational marker selection for phenotyping (up to 35 total antibodies). An evaluation of specimen adequacy and cellular integrity will also be performed.

Preparation and staining of blood smears for the identification and enumeration of blood cells.

Genoptix offers a comprehensive catalog of over 200 high-quality IHC antibodies and stains including stains for leukemia, lymphoma, breast cancer, prostate cancer, and more. You can easily pick and choose from our full menu–available in both global (with interpretation) or tech-only (no interpretation) options. When you order as tech-only, you’ll receive your digital slide images within one business day. Then, simply analyze and interpret the results. With the Genoptix Report Builder tool, you can easily review digital slide images and build a customized professional report. Don’t have time? Convert your case to global, and one of our expert pathologists will perform the interpretation for you.

Download our list of IHC stains

Chromosomal gains, losses, deletions, inversions, or translocations commonly associated with various hematological disorders and solid tumors are detected by fluorescence in situ hybridization (FISH).

Chromosomal gains, losses, deletions, inversions, or translocations commonly associated with various hematological disorders and solid tumors are detected by chromosome analysis.

Preparation of blood smears and/or bone marrow core/clot for staining, morphological identification and enumeration of hematopoietic cells.